|
ATE308981T1
(de)
*
|
1995-08-14 |
2005-11-15 |
Scripps Research Inst |
Verfahren und mittel zur hemmung der durch alpha v beta 5 vermittelten angiogenese
|
|
US7053041B1
(en)
*
|
1996-05-31 |
2006-05-30 |
The Scripps Research Institute |
Methods and compositions useful for inhibition of αvβ5mediated angiogenesis
|
|
US20040063790A1
(en)
*
|
1996-05-31 |
2004-04-01 |
The Scripps Research Institute |
Methods for inhibition of angiogenesis
|
|
US20050281821A1
(en)
*
|
1999-01-06 |
2005-12-22 |
Flavia Pernasetti |
Method and composition for angiogenesis inhibition
|
|
DE60045314D1
(de)
*
|
1999-10-06 |
2011-01-13 |
Kaneka Corp |
Verfahren zur herstellung eines polyimidharzes
|
|
ATE412895T1
(de)
*
|
2001-02-21 |
2008-11-15 |
Eisai R&D Man Co Ltd |
Verfahren zur untersuchung der wirkung eines angiogenese-hemmers unter vermittlung durch hemmung der integrin-expression
|
|
US7019108B2
(en)
*
|
2001-06-01 |
2006-03-28 |
University Of Southern California |
Method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within MMP-2
|
|
AU2002319282B2
(en)
*
|
2001-08-01 |
2007-06-28 |
Merck Patent Gmbh |
Integrin inhibitors for the treatment of eye diseases
|
|
US7301006B2
(en)
*
|
2002-07-16 |
2007-11-27 |
Wisconsin Alumni Research Foundation |
Methods and materials for the synthesis of modified peptides
|
|
FR2856598B1
(fr)
*
|
2003-06-25 |
2005-10-28 |
Inst Nat Sante Rech Med |
Peptides derives de la proteine mmp-2 et leur utilisation en immunotherapie antitumorale
|
|
CN101072797B
(zh)
|
2004-03-12 |
2012-05-09 |
瓦斯基因治疗公司 |
结合ephb4、抑制血管发生和肿瘤生长的抗体
|
|
RU2361614C2
(ru)
*
|
2004-03-24 |
2009-07-20 |
ПиДиЭл БАЙОФАРМА, ИНК. |
ПРИМЕНЕНИЕ АНТИТЕЛ ПРОТИВ α5β1 ДЛЯ ИНГИБИРОВАНИЯ ПРОЛИФЕРАЦИИ РАКОВЫХ КЛЕТОК
|
|
MXPA06011851A
(es)
*
|
2004-04-14 |
2006-12-14 |
Genentech Inc |
Composiciones y metodos para moduilar el desarrollo vascular.
|
|
US7973134B2
(en)
*
|
2004-07-07 |
2011-07-05 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in anaplastic large cell lymphoma signaling pathways
|
|
CA2581423A1
(en)
|
2004-09-23 |
2006-03-30 |
Vasgene Therapeutics, Inc. |
Polipeptide compounds for inhibiting angiogenesis and tumor growth
|
|
US7935790B2
(en)
*
|
2004-10-04 |
2011-05-03 |
Cell Singaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in T-cell receptor signaling pathways
|
|
US7807789B2
(en)
*
|
2004-12-21 |
2010-10-05 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in EGFR-signaling pathways
|
|
EP1836223B1
(en)
*
|
2005-01-03 |
2011-11-23 |
F. Hoffmann-La Roche AG |
Method for identifying a nucleic acid encoding a hemopexin-like structure which specifically binds a predetermined target molecule.
|
|
BRPI0608272A2
(pt)
*
|
2005-02-24 |
2009-12-08 |
Scripps Research Inst |
método para promover revascularização fisiológica benéfica de tecido retinal isquêmico e método de triagem para identificar e avaliar a eficácia terapêutica de agentes terapêuticos potenciais para tratar doenças neovasculares retinais
|
|
US20090099340A1
(en)
*
|
2007-10-12 |
2009-04-16 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
|
|
US20060286148A1
(en)
*
|
2005-05-18 |
2006-12-21 |
Ppd, Inc. |
Method of forming implants
|
|
US20070048325A1
(en)
*
|
2005-08-24 |
2007-03-01 |
Dennis Van Epps |
Combination therapies for inhibiting integrin-extracellular matrix interactions
|
|
US20100151495A9
(en)
*
|
2005-08-31 |
2010-06-17 |
Cell Signaling Technolgy, Inc. |
Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
|
|
EP1934867A2
(en)
*
|
2005-08-31 |
2008-06-25 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in leukemia signaling pathways
|
|
CA2621380A1
(en)
*
|
2005-09-20 |
2007-03-29 |
Embrex, Inc. |
Methods for rapidly and accurately locating avian egg blastoderms
|
|
SG10201804008UA
(en)
*
|
2005-11-04 |
2018-06-28 |
Genentech Inc |
Use of complement pathway inhibitors to treat ocular diseases
|
|
SG10201400426XA
(en)
|
2006-01-12 |
2014-07-30 |
Alexion Pharma Inc |
Antibodies to ox-2/cd200 and uses thereof
|
|
AU2007213920B2
(en)
*
|
2006-02-09 |
2013-08-29 |
Amgen Research (Munich) Gmbh |
Treatment of metastatic breast cancer
|
|
US20090298093A1
(en)
*
|
2006-04-27 |
2009-12-03 |
Roberto Polakiewicz |
Reagents for the Detection of Protein Phosphorylation in ATM & ATR Kinase Signaling Pathways
|
|
EP1862541A1
(en)
*
|
2006-06-01 |
2007-12-05 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Polypeptides derived from the hemopexin-like domain of metalloproteinase MMP-2
|
|
US7939636B2
(en)
*
|
2006-08-11 |
2011-05-10 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in c-Src signaling pathways
|
|
US20090258442A1
(en)
*
|
2006-08-31 |
2009-10-15 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
|
|
MX2009008222A
(es)
|
2007-02-01 |
2009-10-12 |
Acceleron Pharma Inc |
Antagonistas de activina-actriia y usos para tratar o prevenir cancer de mama.
|
|
US20090081659A1
(en)
|
2007-03-07 |
2009-03-26 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
|
|
US20090068684A1
(en)
*
|
2007-03-26 |
2009-03-12 |
Cell Signaling Technology, Inc. |
Serine and threoninephosphorylation sites
|
|
US20080238709A1
(en)
*
|
2007-03-28 |
2008-10-02 |
Faramarz Vaziri |
One-way communication apparatus with dynamic key generation
|
|
US7977462B2
(en)
|
2007-04-19 |
2011-07-12 |
Cell Signaling Technology, Inc. |
Tyrosine phosphorylation sites
|
|
EP2145902A3
(en)
|
2007-04-19 |
2010-09-29 |
Peter Hornbeck |
Tyrosine phosphorylation sites and antibodies specific for them
|
|
EP1983003A3
(en)
|
2007-04-19 |
2009-03-11 |
Peter Hornbeck |
Tyrosine phosphorylation sites and antibodies specific for them
|
|
US20090053831A1
(en)
|
2007-05-01 |
2009-02-26 |
Cell Signaling Technology, Inc. |
Tyrosine phosphorylation sites
|
|
CN101861161B
(zh)
|
2007-09-18 |
2017-04-19 |
阿塞勒隆制药公司 |
活化素‑actriia拮抗剂和减少或抑制fsh分泌的用途
|
|
US20090203043A1
(en)
|
2007-11-21 |
2009-08-13 |
Peter Hornbeck |
Protein phosphorylation by basophilic serine/threonine kinases in insulin signaling pathways
|
|
US20090220991A1
(en)
*
|
2008-02-29 |
2009-09-03 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in leukemia signaling pathways
|
|
US11673914B2
(en)
|
2009-11-10 |
2023-06-13 |
Allegro Pharmaceuticals, LLC |
Peptide therapies for reduction of macular thickening
|
|
MX346362B
(es)
|
2009-11-10 |
2017-03-15 |
Allegro Pharmaceuticals Inc * |
Composiciones y metodos para inhibir la adhesion celular o dirigir agentes de diagnostico o terapeuticos a sitios de enlace rgd.
|
|
RU2429836C1
(ru)
*
|
2010-04-01 |
2011-09-27 |
Максуд Мухамеджанович Расулов |
СРЕДСТВО, СТИМУЛИРУЮЩЕЕ ЭКСПРЕССИЮ МАТРИЧНОЙ РНК ТРИПТОФАНИЛ-тРНК-СИНТЕТАЗЫ
|
|
NZ610230A
(en)
*
|
2010-10-07 |
2015-07-31 |
Aerpio Therapeutics Inc |
Compositions and methods for treating ocular edema, neovascularization and related diseases
|
|
KR102165421B1
(ko)
|
2011-05-09 |
2020-10-14 |
알레그로 파마슈티칼스, 인코포레이티드. |
인테그린 수용체 길항물질 및 이의 사용 방법
|
|
CA2868883C
(en)
|
2012-03-30 |
2022-10-04 |
Sorrento Therapeutics Inc. |
Fully human antibodies that bind to vegfr2
|
|
EP4026849A1
(en)
|
2016-09-26 |
2022-07-13 |
Ensemble Group Holdings |
Methods of assessing and treating cancer in subjects having dysregulated lymphatic systems using a combination of vegfr-3 and pd-1 or pd-l1 inhibitors
|
|
MX2019011717A
(es)
*
|
2017-03-31 |
2019-12-16 |
Univ California |
Composiciones y metodos para focalizar y matar celulas madre positivas a cancer alfa-v beta-3 y tratar cancer resistentes a farmacos.
|
|
CN113663929A
(zh)
*
|
2021-09-24 |
2021-11-19 |
深圳市广利达精密机械有限公司 |
一种自动化机械加工零件自动加工分拣设备及其方法
|